Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 373 results found since Jan 2013.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
Publication date: Available online 12 September 2016 Source:The Lancet Author(s): Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser Background Tight control of blood glucose in type 1 diabetes delays onset of macrovascular and microvascular diabetic complications; however, glucose levels need to be closely monitored to prevent hypoglycaemia. We aimed to assess whether a factory-calibrated, sensor-based, flash glucose-monitoring system compared with self-monitored glucose testing reduced exposure to hypoglycaemia in patients with type 1 diabetes. Method In this multicentre, pros...
Source: The Lancet - September 11, 2016 Category: Journals (General) Source Type: research
Want to detect gluten on the go? There ’ s a device for that
(Reuters) – A California startup has developed a portable technology that will allow consumers to test their food for gluten on the go.
“Even when you go out and see these labeled menu items, you are still playing Russian roulette,” said Shireen Yates, co-founder and chief executive of NIMA, which was founded in 2013.
Designed in San Francisco by a team from MIT, Stanford, Google and Nike, NIMA can analyze any type of food or beverage for gluten down to 20 parts per million, the Food and Drug Administration (FDA) classification for gluten-free products.
“There is still cross contamination, there is...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: MassDevice Tags: Diagnostics Nima Source Type: news
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial
This study is registered with ClinicalTrials.gov, number NCT01810289. Findings Between April 11, 2013, and Feb 2, 2015, 12 024 eligible patients visited one of the 20 participating clinics. Median CD4 count was 310 cells per μL (IQR 179–424). 3753 of 4747 patients (weighted proportion 80%) in the intervention group had started ART by 2 weeks after eligibility compared with 2585 of 7066 patients (38%) in the control group (risk difference 41·9%, 95% CI 40·1–43·8). Vital status was ascertained in a random sample of 208 patients in the intervention group and 199 patients in the control group. Four deaths (2%) occurr...
Source: The Lancet HIV - August 26, 2016 Category: Infectious Diseases Source Type: research
Has EpiPen Price Gouger Mylan Silenced Allergy Advocates?
Prominent allergy advocacy groups have yet to criticize pharmaceutical maker Mylan for its 480% price hike on lifesaving EpiPens. Is it because they receive funding from Mylan?
Source: Forbes.com Healthcare News - August 25, 2016 Category: Pharmaceuticals Authors: Nancy Fink Huehnergarth Source Type: news
Appeals court ruling protects marijuana doctors from prosecution
A new appellate ruling protects doctors from federal prosecution when they recommend medical marijuana in accordance with state law.
In an Aug. 16 opinion, the 9th U.S. Circuit Court of Appeals ruled that the U.S. Department of Justice cannot spend funding to prosecute physicians and patients who...
Source: Skin and Allergy News - August 19, 2016 Category: Dermatology Source Type: news
Leading Digital Transformation
The freshly minted role of Chief Digital Officer is enjoying something of a boom.“At the end of 2015, there were approximately 2,000 CDOs. CDO hires have been doubling every year and I expect there to be 2,500 CDOs by the end of 2016,” the CDO Club’s CEO David Mathison noted recently.1But what ’s fuelling this trend? Quite simply, traditional businesses have woken up to the need fordigital transformation as customers demand new ways of engaging with businesses and the companies themselves look to improve the customer experience, streamline processes and reap the benefits of innovation down the length of the value ...
Source: EyeForPharma - August 18, 2016 Category: Pharmaceuticals Authors: Nick de Cent Source Type: news
Top NIH doctor on new U.S. Zika cases, Congress funding
In Florida, it is all but certain that four Zika cases came from local mosquitoes. Well over 1,600 travel-related cases are reported in the U.S. Meanwhile, Congress went on its summer recess without approving funds to fight Zika. Now Senate Democrats want members to cut their break short. National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci joins "CBS This Morning" from Bethesda, Maryland, to discuss the Zika threat.
Source: Health News: CBSNews.com - August 1, 2016 Category: Consumer Health News Source Type: news
Lawmakers Enjoy Vacation While Zika Spreads To U.S.
WASHINGTON ― Democrats in Congress called on leaders Friday to interrupt a seven-week vacation and return to Capitol Hill after the first local outbreak of the Zika virus was reported in Florida.
Congress failed to pass emergency legislation to fund the nation’s response to Zika before legislators departed earlier this month, first to attend the party conventions and then to take time off.
But with news that at least four people had contracted Zika locally in Southern Florida and the conventions over, Democrats were quick to say it’s time to come back to work.
“I call on Republican Congressional leaders...
Source: Healthy Living - The Huffington Post - July 29, 2016 Category: Consumer Health News Source Type: news
UAB research team awarded $11.5M contract
A group of researchers at the University of Alabama at Birmingham was recently awarded an $11.5 million contract to study treatment of babies born with congenital cytomegalovirus and frequency of neonatal herpes infections in the United States and Peru.
The National Institute of Allergy and Infectious Disease awarded the funding to the UAB Department of Pediatrics to support two studies slated to be conducted at UAB and its partner academic sites.
Nearly 1 percent of babies born in the United States…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 15, 2016 Category: Pharmaceuticals Authors: Tim Steere Source Type: news
NIH expands investment in HIV cure research
(NIH/National Institute of Allergy and Infectious Diseases) NIH has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure program and are a part of President Barack Obama's pledge to invest in HIV cure research.
Source: EurekAlert! - Medicine and Health - July 13, 2016 Category: Global & Universal Source Type: news
Heterogeneity of the HIV epidemic in agrarian, trading, and fishing communities in Rakai, Uganda: an observational epidemiological study
Publication date: Available online 9 July 2016 Source:The Lancet HIV Author(s): Larry W Chang, Mary K Grabowski, Robert Ssekubugu, Fred Nalugoda, Godfrey Kigozi, Betty Nantume, Justin Lessler, Sean M Moore, Thomas C Quinn, Steven J Reynolds, Ronald H Gray, David Serwadda, Maria J Wawer Background Understanding the extent to which HIV burden differs across communities and the drivers of local disparities is crucial for an effective and targeted HIV response. We assessed community-level variations in HIV prevalence, risk factors, and treatment and prevention service uptake in Rakai, Uganda. Methods The Rakai ...
Source: The Lancet HIV - July 9, 2016 Category: Infectious Diseases Source Type: research
Zika Sex Research Begins Despite U.S. Congress Funding ImpasseZika Sex Research Begins Despite U.S. Congress Funding Impasse
It could take years to learn how long men infected with Zika are capable of sexually transmitting the virus, which can cause crippling birth defects and other serious neurological disorders. Reuters Health Information
Source: Medscape Allergy Headlines - July 1, 2016 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
NIAID funding to Jackson Laboratory researcher to investigate chronic fatigue syndrome
(Jackson Laboratory) Professor Derya Unutmaz, M.D., of The Jackson Laboratory for Genomic Medicine, will receive five years of funding -- totaling $3,281,515 from the National Institute of Allergy and Infectious Diseases -- to find better ways to diagnose and treat myalgic encephalomyelitis, the debilitating and mysterious condition more generally known as chronic fatigue syndrome.
Source: EurekAlert! - Medicine and Health - June 7, 2016 Category: Global & Universal Source Type: news
D.C. Week: House, Senate Split on Zika Funding
(MedPage Today) -- Also, SCOTUS punts on Affordable Care Act birth control coverage issue
Source: MedPage Today Allergy - May 21, 2016 Category: Allergy & Immunology Source Type: news
House Republicans Are Happy To Dither As Zika Threat Looms
Public health officials are growing more and more concerned about the Zika virus as its true impact in South and Central America becomes clear. In January, the World Health Organization said Zika could be on the verge of spreading throughout the Americas. Health organizations in the U.S. are upping their efforts to develop a vaccine and eradicate the virus, and the White House has asked that money be appropriated to help make this happen.
But as certain as death and taxes, Republicans in the House of Representatives have emerged to slow this process to a crawl. GOP lawmakers have met these calls to action with indifference...
Source: Science - The Huffington Post - May 5, 2016 Category: Science Source Type: news
